Blood cancers confer high COVID-19 risk

Leukaemia doubles the chance of dying from coronavirus compared with other malignancies, and recent chemotherapy further increases risk, a study shows

When it comes to the risk from COVID-19, not all cancers are equal, according to findings from a UK cohort study showing patients with haematological cancers are particularly vulnerable.

coronavirus and red blood cells

Data for 1044 people with active cancer who tested positive for the SARS-CoV-2 virus between March and May across 61 centres in the UK Coronavirus Cancer Monitoring Project were compared with control population data on people with cancer from 2017.

Some 31% of the people with COVID-19